Lyumjev ® (insulin lispro)

För fullständig produktresumé för Lyumjev se FASS.

Denna information är endast avsedd för sjukvårdspersonal verksam i Sverige och som svar på din fråga. Informationen nedan är på engelska

Lyumjev® ▼ (insulin lispro): Användning hos gravida och ammande kvinnor

Lyumjev har inte studerats hos gravida eller ammande kvinnor.

Further information

A large amount of data on pregnant women (more than 1000 pregnancy outcomes) for insulin lispro is available. URLi (LY900014) can be used during pregnancy if clinically needed.1

The decision remains at the discretion of the prescribing physician.

Talk to your healthcare provider

If you are

  • planning to have a baby,

  • think you may be pregnant,

  • are pregnant,

ask your doctor, nurse or pharmacist for advice before taking this medicine.2

The amount of insulin you need usually falls during the first 3 months of pregnancy and increases for the remaining 6 months. After you have had your baby your insulin requirements will likely return to how much you needed before your pregnancy.2

Talk to your healthcare provider about how to maintain good glucose control during pregnancy.

References

1. Lyumjev [summary of product characteristics]. Eli Lilly Nederland B.V., The Netherlands.

2. Lyumjev [Package leaflet: Information for the user]. Eli Lilly Nederland B.V., The Netherlands.

This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information. Healthcare professionals are asked to report any suspected adverse reactions.

Datum fӧr senaste ӧversyn January 24, 2020


Kontakta Medicinsk Information på Lilly

Kontakta oss på telefon

Kontorstid vardagar 9.00-17.00

Eller så kan du

Klicka för att chatta är tillgänglig

Klicka för att chatta är offline

Skriv din fråga till oss